Product Information
VASCEPA 1 GM CAPSULE is a brand product labeled by Amarin Pharma Inc., priced at $2.8366 per EA under NDC 52937000120. Its NADAC has been published 567 times since Nov 28, 2013.
FDA first approved this application on Jul 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the icosapent ethyl market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1000 mg/1
Manufacturer
Amarin Pharma Inc.NDC
52937000120
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/18/2024
Active Ingredients
ICOSAPENT ETHYLApproval Type
New Drug (NDA)
FDA Application
NDA202057FDA Approved
7/26/2012
TE Code
AB
On Market Since
10/1/2012
Price Statistics
The NADAC for VASCEPA 1 GM CAPSULE has been published 567 times since Nov 28, 2013, and over the history we have for it it has risen 92.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.8366 per EA |
|---|---|
| All-time high | $2.8374 (Feb 15, 2023) |
| All-time low | $1.4760 (Nov 28, 2013) |
| Median price | $2.4265 |
| Average price | $2.3293 |
| Largest weekly change | +9.0% (Jan 8, 2020) |
| Weeks tracked | 567 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+0.0%
5Y
+3.0%
All
+92.2%
Last surveyed Oct 2, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the icosapent ethyl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VASCEPA 1 GM CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VASCEPA 1 GM CAPSULE, manufactured by Amarin Pharma Inc., is $2.8366 per EA (NDC 52937000120), effective Oct 2, 2024.
How has the price of VASCEPA 1 GM CAPSULE changed over time?
Over the history we have for it, the NADAC for VASCEPA 1 GM CAPSULE has risen 92.2%. It has been tracked across 567 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VASCEPA 1 GM CAPSULE?
Since Nov 28, 2013, the NADAC for VASCEPA 1 GM CAPSULE has ranged from a low of $1.4760 (Nov 28, 2013) to a high of $2.8374 (Feb 15, 2023), with a median of $2.4265 per EA.
Are there cheaper alternatives to VASCEPA 1 GM CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of VASCEPA 1 GM CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VASCEPA 1 GM CAPSULE?
VASCEPA 1 GM CAPSULE (NDC 52937000120) is labeled by Amarin Pharma Inc., and CMS classifies it as a brand product.